Suchergebnisse - "Calabretta, Eleonora"

PubPharm (8)

1

Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma

enthalten in: British journal of haematology | 2024

von Calabretta, E. | di Trani, M. | Corrado, F. | +10

2

Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma

enthalten in: British Journal of Haematology | 2024

von Calabretta, E. | Trani, M. | Corrado, F. | +10

3

The antibody-drug conjugate loncastuximab tesirine for the treatment of diffuse large B-cell lymphoma

enthalten in: Blood | 2022

von Calabretta, E. | Hamadani, M. | Zinzani, P. | +2

4

Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma : Outcomes and clonal evolution dynamics

enthalten in: British journal of haematology | 2022

von Calabretta, E. | Guidetti, A. | Ricci, F. | +15

5

Defibrotide : potential for treating endothelial dysfunction related to viral and post-infectious syndromes

enthalten in: Expert opinion on therapeutic targets | 2021

von Richardson, E. | García-Bernal, D. | Calabretta, E. | +11

6

COVID-19-induced endotheliitis : emerging evidence and possible therapeutic strategies

enthalten in: British journal of haematology | 2021

von Calabretta, E. | Moraleda, J. | Iacobelli, M. | +11

7

The Many Facets of CD38 in Lymphoma : From Tumor-Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy

enthalten in: Cells | 2020

von Calabretta, E. | Carlo-Stella, C.

8

Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma

enthalten in: International journal of molecular sciences | 2019

von Calabretta, E. | d'Amore, F. | Carlo-Stella, C.

1
[1]